254 related articles for article (PubMed ID: 18216320)
1. Latent TGF-beta1 protects against crescentic glomerulonephritis.
Huang XR; Chung AC; Zhou L; Wang XJ; Lan HY
J Am Soc Nephrol; 2008 Feb; 19(2):233-42. PubMed ID: 18216320
[TBL] [Abstract][Full Text] [Related]
2. Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
Tang YJ; Xiao J; Huang XR; Zhang Y; Yang C; Meng XM; Feng YL; Wang XJ; Hui DS; Yu CM; Lan HY
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):761-71. PubMed ID: 24885478
[TBL] [Abstract][Full Text] [Related]
3. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.
Ka SM; Huang XR; Lan HY; Tsai PY; Yang SM; Shui HA; Chen A
J Am Soc Nephrol; 2007 Jun; 18(6):1777-88. PubMed ID: 17475816
[TBL] [Abstract][Full Text] [Related]
4. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
[TBL] [Abstract][Full Text] [Related]
5. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
6. Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease.
Huang XR; Chung AC; Wang XJ; Lai KN; Lan HY
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F118-27. PubMed ID: 18448597
[TBL] [Abstract][Full Text] [Related]
7. Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling.
Wu W; Huang XR; You Y; Xue L; Wang XJ; Meng X; Lin X; Shen J; Yu X; Lan HY; Chen H
Int J Biol Sci; 2021; 17(13):3583-3594. PubMed ID: 34512167
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis.
Song CY; Kim BC; Hong HK; Lee HS
Kidney Int; 2007 May; 71(9):882-8. PubMed ID: 17299519
[TBL] [Abstract][Full Text] [Related]
9. [Effect of enalapril on the expression of TGF-beta1, p-Smad2/3 and Smad7 in renal interstitial fibrosis in rats].
Ning W; Tao L; Liu C; Sun J; Xiao Y; Hu J; Chen J; Zheng X; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):27-34. PubMed ID: 19197123
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.
Chung AC; Huang XR; Zhou L; Heuchel R; Lai KN; Lan HY
Nephrol Dial Transplant; 2009 May; 24(5):1443-54. PubMed ID: 19096081
[TBL] [Abstract][Full Text] [Related]
11. The Regulatory T-cell Transcription Factor Foxp3 Protects against Crescentic Glomerulonephritis.
Yang C; Huang XR; Fung E; Liu HF; Lan HY
Sci Rep; 2017 May; 7(1):1481. PubMed ID: 28469165
[TBL] [Abstract][Full Text] [Related]
12. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY
Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013
[TBL] [Abstract][Full Text] [Related]
13. [Dynamic expression of TGF-beta1/Smad protein in CCl4-induced liver fibrosis and its significance in rats].
Bao JF; Shi JP; Xu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):334-7. PubMed ID: 22338217
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline inhibits transforming growth factor-beta signaling and renal fibrosis in experimental crescentic glomerulonephritis in rats.
Ng YY; Chen YM; Tsai TJ; Lan XR; Yang WC; Lan HY
Am J Nephrol; 2009; 29(1):43-53. PubMed ID: 18679024
[TBL] [Abstract][Full Text] [Related]
15. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine inhibits renal fibrosis of obstructive nephropathy by downregulating the TGF-β1-Smad3 pathway.
Wang HW; Shi L; Xu YP; Qin XY; Wang QZ
Ren Fail; 2016 Jul; 38(6):945-51. PubMed ID: 27050799
[TBL] [Abstract][Full Text] [Related]
17. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
19. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.
Liu GX; Li YQ; Huang XR; Wei L; Chen HY; Shi YJ; Heuchel RL; Lan HY
PLoS One; 2013; 8(1):e53573. PubMed ID: 23301086
[TBL] [Abstract][Full Text] [Related]
20. Molecular validation of the precision-cut kidney slice (PCKS) model of renal fibrosis through assessment of TGF-β1-induced Smad and p38/ERK signaling.
Zhang S; Liu Q; Xiao J; Lei J; Liu Y; Xu H; Hong Z
Int Immunopharmacol; 2016 May; 34():32-36. PubMed ID: 26919280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
